Novelion Therapeutics Overview
- Year Founded
-
1981
- Status
-
Out of Business
- Employees
-
109
- Latest Deal Type
-
Liquidation
- Financing Rounds
-
7
- Investments
-
8
Novelion Therapeutics General Information
Description
Developer of rare disease drugs based in Vancouver, Canada. The company specializes in developing pharmaceutical drugs catering to people suffering from diseases like lipodystrophy, Leber congenital amaurosis, and retinitis pigmentosa.
Contact Information
Website
www.novelion.comCorporate Office
- 1800 - 510 West Georgia Street
- Vancouver, British Columbia V6B 0M3
- Canada
Corporate Office
- 1800 - 510 West Georgia Street
- Vancouver, British Columbia V6B 0M3
- Canada
Novelion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novelion Therapeutics Comparisons
Industry
Financing
Details
Novelion Therapeutics Competitors (96)
One of Novelion Therapeutics’s 96 competitors is Abeona Therapeutics, a Corporation company based in Cleveland, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Santhera Pharmaceuticals Holding | Formerly VC-backed | Pratteln, Switzerland | ||||
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Novelion Therapeutics Patents
Novelion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015023902-A3 | Improving visual function associated with impaired dark adaptation and/or impaired low luminance vision | Inactive | 14-Aug-2013 | ||
| WO-2015023902-A2 | Therapeutic regimens and methods for improving visual function in visual disorders associated with impaired dark adaptation and/or impaired low luminance vision | Inactive | 14-Aug-2013 | ||
| US-20140094484-A1 | Sustained delivery formulations of rapamycin compounds | Inactive | 02-Oct-2012 | ||
| WO-2013164671-A1 | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension | Inactive | 03-May-2012 | ||
| US-20130253411-A1 | Photodynamic therapy laser | Active | 21-Mar-2012 | A61F9/00821 |
Novelion Therapeutics Signals
Novelion Therapeutics Investments & Acquisitions (8)
Novelion Therapeutics’s most recent deal was a Merger/Acquisition with Aegerion Pharmaceuticals for . The deal was made on 29-Nov-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aegerion Pharmaceuticals | 29-Nov-2016 | Merger/Acquisition | Drug Discovery | ||
| Aralez Pharmaceuticals | 05-Feb-2016 | PIPE | Pharmaceuticals | ||
| Othera Pharmaceuticals (OT-730 drug) | 30-Dec-2009 | Corporate Asset Purchase | Buildings and Property | ||
| ForSight NewCo | 19-Oct-2007 | Merger/Acquisition | Drug Delivery | ||
| ForSight Vision2 | 18-Oct-2007 | Merger/Acquisition | Drug Delivery |
Novelion Therapeutics Exits (3)
Novelion Therapeutics’s most recent exit was on 29-Nov-2016 from Aegerion Pharmaceuticals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aegerion Pharmaceuticals | 29-Nov-2016 | Completed |
|
||
| Aralez Pharmaceuticals | 05-Feb-2016 | Completed |
|
||
| Tribute Pharmaceuticals | 04-Jun-2004 | Early Stage VC | Completed |
|
Novelion Therapeutics FAQs
-
When was Novelion Therapeutics founded?
Novelion Therapeutics was founded in 1981.
-
Where is Novelion Therapeutics headquartered?
Novelion Therapeutics is headquartered in Vancouver, Canada.
-
What is the size of Novelion Therapeutics?
Novelion Therapeutics has 109 total employees.
-
What industry is Novelion Therapeutics in?
Novelion Therapeutics’s primary industry is Pharmaceuticals.
-
Is Novelion Therapeutics a private or public company?
Novelion Therapeutics is a Private company.
-
What is Novelion Therapeutics’s current revenue?
The current revenue for Novelion Therapeutics is .
-
How much funding has Novelion Therapeutics raised over time?
Novelion Therapeutics has raised $22M.
-
Who are Novelion Therapeutics’s competitors?
Abeona Therapeutics, Genentech, Santhera Pharmaceuticals Holding, Verona Pharma, and Merck & Co. are some of the 96 competitors of Novelion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process